Sponsor:
Walden Biosciences
Code:
NCT06466135
Conditions
Diabetic Nephropathies
Primary Focal Segmental Glomerulosclerosis
Minimal Change Disease
Primary Immunoglobulin A Nephropathy
Primary Membranous Nephropathy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
WAL0921
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-28. This information was provided to ClinicalTrials.gov by Walden Biosciences on 2026-04-02.